Ambev (ABEV) possesses solid growth attributes, which could help it handily outperform the market.
Does Ambev (ABEV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ambev (ABEV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors with an interest in Beverages - Alcohol stocks have likely encountered both Ambev (ABEV) and Brown-Forman B (BF.B). But which of these two stocks presents investors with the better value opportunity right now?
Ambev S.A. (ABEV) Q4 2025 Earnings Call Transcript
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.2%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8% plus.
Consumer confidence has dipped to multi-year lows, yet the coming fiscal stimulus could support consumer spending on essentials. While macro conditions remain mixed, staples' relative stability and essential nature make them compelling considerations for diversified portfolios. Investors looking for defensive exposure can consider opportunities not just in large cap staple giants, but in niche and value-oriented names poised to benefit from macro trends.
Ambev remains a buy, supported by robust financials, strong cash flows, and a compelling dividend yield, despite macro headwinds. ABEV's strong net cash position and limited long-term liabilities provide ample flexibility for future expansion or leverage, boosting their resilience. Near-term catalysts include the 2026 FIFA World Cup, expected to significantly boost summer sales and drive demand recovery.
In November, Seeking Alpha welcomed 24 new analysts. This article introduces them and showcases some of their top picks. Analysts highlighted include The Academic Investor, recommending Galaxy Digital; Richard Doxtator, presenting on Moonlake Immunotherapeutics; and ML Research, writing about Sezzle—all rated Strong Buys. Analysts' diverse interests range from technology (AI, in particular) to digital assets to EM equities, with investment strategies focusing on value and growth investing.
Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Ambev (ABEV) and Brown-Forman B (BF.B). But which of these two stocks offers value investors a better bang for their buck right now?
Ambev S.A. offers stable growth and resilience, supported by strong brands and geographic diversification across Latin America and Canada. Q3 results showed solid EBITDA and earnings growth despite climate and demand pressures, with robust shareholder returns via buybacks and dividends. ABEV is undervalued, with a DCF-based price target of $3.71, implying nearly 50% upside from current levels, and poised for a World Cup-driven boost in 2026.
Here is how Ambev (ABEV) and Chefs' Warehouse (CHEF) have performed compared to their sector so far this year.